Hu et al. have characterized genetic alterations and oncogenic pathway in different breast cancers subtypes, both in tissue and in cell lines, and found that all mutations in BRAF, KRAS and HRAS were significantly associated with the triple negative subtype[55]. The gene discussed is KRAS; the disease is breast carcinoma.